Spot on SB - We have more than 10 years (peer reviewed) data and greater than 20,000 patients proving our anti calcification credentials. It should be noted that a lot of these patients are in the paediatric area and due to fast growth are more prone to calcification issues.
LeMaitre paid a lot of money for a few of our Adapt products because the anti calcification properties were so good and so proven.
A timeline going forward would be greatly appreciated, page-94
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.15 |
Change
0.000(0.00%) |
Mkt cap ! $291.2M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.60 | $347.8K | 23.20K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 760 | $15.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.15 | 388 | 1 |
View Market Depth
| Last trade - 15.58pm 30/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |